While some vaccine skeptics continue believing that vaccines can cause autism and other illness, a few reports suggest a flu jab can make you ill. There are symptoms and some side effects after taking a shot, according to some sources.
The flu jab is used to protect the human body against the influenza virus- a virus that can cause severe illness and may lead to death if not prevented right away. This vaccine contains tiny doses of certain flu strains, which change each year and cause antibodies (protect against infection) in the body to develop.
The flu jab is available every year on the NHS (National Health Service) and some pharmacies.
Some people feared taking flu jab as they worried that it would make them ill. NHS clarifies the vaccine does not give flu.
“The vaccine does not contain any live viruses, so it cannot cause flu,” said.
There could be some symptoms and side effects after taking a flu jab. According to the health expert, a patient may get a slight temperature and aching muscles for a couple of days afterward. Aside from that, a patient's arm may feel a bit sore where you had the injection.
“Other reactions are rare, and flu vaccines have a good safety record," health expert added.
NHS confirmed that the nasal spray vaccine for children would not cause flu because the viruses in it have been weakened to prevent this from happening.
The health expert said there are five groups of ‘at risk’ people who are eligible for the NHS free-of-charge vaccine. People who are eligible for a free flu jab and advised to have the vaccine if they are:
1. Pregnant
2. 65 years of age or over
3. Have certain medical conditions
4. Living in a long-stay residential care home
5. Receiving a carer’s allowance or disabled person whose welfare may be at risk if you fall ill
Frontline health and social care workers are also eligible for the flu jab. However, their employer should arrange and pay for their vaccine.


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash 



